Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics

Cancer Genetics and Cytogenetics

Volumn 97, Issue 2, 1997, Pages 97-100

  Amiel, Aliza ^a   Arbov, Lea ^a,b   Manor, Yosef ^a,b   Fejgin, Moshe ^a   Elis, Avishai ^a,b   Gaber, Elena ^a   Lishner, Michael ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; HUMAN; INTERPHASE; MALE; MALIGNANT TRANSFORMATION; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; ALLELES; CYTOGENETICS; FEMALE; GENE DELETION; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 0030756151     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00341-X     Document Type: Article

References (30)

1. Fiona M, Stockdill RG (1987): Clonal chromosomal abnormalities in chronic lymphocytic leukemia patients revealed by TPA stimulation of whole blood cultures. Cancer Genet Cytogenet 25:109-121.
2. Juliusson G, Gahrton G (1990): Chromosome aberrations in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 45:143-160.
3. Datta T, Bauchinger M, Emmerich B, Reichle A (1991): Chromosome analyses in chronic lymphocytic leukemia and related B-cell neoplasms. Cancer Genet Cytogenet 55:49-56.
4. Klein G (1983): Specific chromosomal translocations and the genesis of B-cell derived tumors in mice and men. Cell 32:311-314.
5. Croce CM (1987): Role of chromosomal translocations in human neoplasia. Cell 36:311-315.
6. Crossen PE (1989): Cytogenetic and molecular changes in chronic B-cell leukemia. Cancer Genet Cytogenet 43:143-150.
7. Gahrton G, Juliusson G (1988): Clinical implications of chromosomal aberrations in chronic B lymphocytic leukemia cells. Nou Rev Fr Hematol 30:389-392.
8. Browett PJ, Ganeshagura K, Hoffbrand AV, North JD (1988): Absence of kirsten-ras oncogene activation in B-cell chronic lymphocytic leukemia. Leukemia Res 12:25-31.
9. Rechavi G, Katzir N, Brok-Simoni F, Holtzman F, Mandel M, Gurfinkel N, Givol D, Ben-Bassat I, Ramot B (1989): A search for bcl-1, bcl-2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. 3:57-60.
10. Raghoebier S, Van Krieken JHJM, Kluin-Nelemans JC, Gillis A, Van Ommen GJ, Ginseberg AM, Raffeld M, Kluin PM (1991): Oncogene rearrangement in chronic B cell leukemia. Blood 77:1560-1564.
11. Lishner M, Lalkin A, Klein A, Yarkoni S, Manor Y, Fejgin M, Leytin V, Ravid M, Amiel A (1995): The bcl-1, bcl-2 and bcl-3 oncogenes are involved in chronic lymphocytic leukemia: Detection by fluorescence in situ hybridization. Cancer Genet Cytogenet 85:118-123.
12. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P (1991): p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Brit J Cancer 63:317-319.
13. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993): Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node negative breast cancer. J Natl Cancer Inst 85:200-206.
14. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM (1992): Accumulation of p53 correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828-4831.
15. Gaidano G, Ballerini P. Gony JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Della-Favera R (1991): p53 mutations in human lymphid malignancies: Association with Burkitt's lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417.
16. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheaux-Lefebvre MH, Bauters F, Berger R, Kerchaert JP (1992): Mutations of the p53 gene in B-chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis. Leukemia 6:246-250.
17. El Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, NewComb EW (1993): p53 mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 82:3452-3459.
18. Juliusson G, Oscier D, Gahrton G for the International working Party on chromosomes in CLL (IWCCLL) (1991): Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation data on 662 patients. Leukemia Lymph 5:21-25.
19. Levine AJ, Momand J, Finlay CA (1991): The p53 tumor supressor gene. Nature 351:453-456.
20. Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilyenbauer S, Volkman M, Galle PR, Poustka A, Hunstein W, Lichter P (1995): p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580-1589.
21. Farrugia MM, Duan LJ, Reis MD, Ngan BQ Y, Berenstein NL (1994): Alternations of the p53 tumor supressor gene in diffuse large cell lymphomas with translocations of the c-myc and BCL-2 proto-oncogenes. Blood 83:191-198.
22. Farrell PJ, Allan CJ, Shanahan F, Vousden KH, Crook T (1991): p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO 10:2879-2883.
23. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hiari H, Ishikawa F, Takaku F (1991): Mutations of the p53 gene in lymphoid leukemias. Blood 77:1153-1156.
24. Neri A, Baldini L, Trecca D, Cro L, Polli E, Maiolo AT (1993): p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81:128-135.
25. Coco, FL, Gaidano G, Louis DC, Offit K, Chaganti RSK, Della-Favera R (1993): p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289-2295.
26. Sander CA, Yano T, Clark HM, Harris C. Longo DL, Jaffe ES, Raffeed M (1993): p53 mutation is associated with progression of follicular lymphomas. Blood 82:1194-2204.
27. Amiel A, Gaber E, Manor Y, Fejgin M, Josef-Lerner M, Ravid M, Lishner M (1995): Fluoresence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia vera. Cancer Genet Cytogenet 79:153-156.
28. Lalkin A, Lishner M, Gaber E, Manor Y, Fejgin M, Ravid M, Amiel A (1993): In situ hybridization: A simple and sensitive method for detection of trisomy 12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet 70:21-24.
29. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M, Lichter P (1993): High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 8:2118-2124.
30. Amiel A, Elis A, Manor Y, Tangi I, Fejgin M, Lishner M (1996): Fluoresence in situ hybridization (FISH) for the detection of trisomy 8 in acute myeloblastic leukemia. Leukemia Lymph 18:179-184.